China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 5.19
+0.13 (2.57%)
Apr 1, 2025, 4:08 PM HKT
HKG:3320 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | 3,854 | 3,500 | 3,769 | 3,297 | Upgrade
|
| Depreciation & Amortization | - | 3,164 | 2,558 | 2,822 | 2,444 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -63.85 | -334.84 | -9.61 | 17.85 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1,161 | 1,101 | 265.44 | 678.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 21.34 | -17.41 | -124.79 | -107.87 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -417.11 | -332.34 | -313.6 | -206.85 | Upgrade
|
| Stock-Based Compensation | - | 141.89 | 99.55 | 1.43 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 450.67 | 478.75 | 455.81 | 780.42 | Upgrade
|
| Other Operating Activities | - | 5,636 | 4,369 | 5,677 | 5,066 | Upgrade
|
| Change in Accounts Receivable | - | -6,077 | -6,441 | -4,727 | -5,034 | Upgrade
|
| Change in Inventory | - | -2,668 | -2,233 | -3,411 | -805.55 | Upgrade
|
| Change in Accounts Payable | - | 10,910 | 8,109 | 7,537 | 1,541 | Upgrade
|
| Change in Unearned Revenue | - | 279.44 | 704.95 | 894.12 | 573.25 | Upgrade
|
| Change in Other Net Operating Assets | - | -842.7 | -741.93 | 7.67 | -37.36 | Upgrade
|
| Operating Cash Flow | - | 15,550 | 10,821 | 12,843 | 8,206 | Upgrade
|
| Operating Cash Flow Growth | - | 43.70% | -15.74% | 56.50% | 0.80% | Upgrade
|
| Capital Expenditures | - | -2,523 | -2,279 | -2,415 | -1,669 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 176.95 | 73.05 | 143.71 | 94.94 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,737 | -1,163 | Upgrade
|
| Divestitures | - | 39.85 | 422.15 | 234.11 | 946.58 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -476.91 | -302.51 | -601.81 | -368.31 | Upgrade
|
| Investment in Securities | - | -835.49 | 267.68 | -4,919 | 18.8 | Upgrade
|
| Other Investing Activities | - | 1,552 | 999.86 | 103.38 | -168.94 | Upgrade
|
| Investing Cash Flow | - | -2,067 | -819.24 | -9,191 | -2,255 | Upgrade
|
| Short-Term Debt Issued | - | - | 2,304 | 2,523 | 6,972 | Upgrade
|
| Long-Term Debt Issued | - | 85,184 | 88,175 | 91,379 | 55,086 | Upgrade
|
| Total Debt Issued | - | 85,184 | 90,479 | 93,902 | 62,058 | Upgrade
|
| Short-Term Debt Repaid | - | -5,213 | - | -2,202 | -8,952 | Upgrade
|
| Long-Term Debt Repaid | - | -82,426 | -93,884 | -85,640 | -55,978 | Upgrade
|
| Total Debt Repaid | - | -87,639 | -93,884 | -87,842 | -64,930 | Upgrade
|
| Net Debt Issued (Repaid) | - | -2,455 | -3,405 | 6,060 | -2,872 | Upgrade
|
| Repurchase of Common Stock | - | - | -3,018 | - | -9.52 | Upgrade
|
| Common Dividends Paid | - | -879.97 | -813.07 | -753.9 | -691.08 | Upgrade
|
| Other Financing Activities | - | -730.22 | -1,890 | -2,301 | -2,842 | Upgrade
|
| Financing Cash Flow | - | -4,065 | -9,126 | 3,005 | -6,415 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 9.66 | 31.92 | -362.69 | -853.81 | Upgrade
|
| Net Cash Flow | - | 9,427 | 907.75 | 6,294 | -1,317 | Upgrade
|
| Free Cash Flow | - | 13,027 | 8,542 | 10,428 | 6,537 | Upgrade
|
| Free Cash Flow Growth | - | 52.51% | -18.09% | 59.52% | 0.69% | Upgrade
|
| Free Cash Flow Margin | - | 5.32% | 3.91% | 4.40% | 3.26% | Upgrade
|
| Free Cash Flow Per Share | - | 2.07 | 1.36 | 1.66 | 1.04 | Upgrade
|
| Cash Interest Paid | - | 2,644 | 1,937 | 2,656 | 2,852 | Upgrade
|
| Cash Income Tax Paid | - | 2,307 | 2,222 | 2,013 | 1,496 | Upgrade
|
| Levered Free Cash Flow | - | 1,765 | 8,338 | -2,987 | -2,489 | Upgrade
|
| Unlevered Free Cash Flow | - | 3,242 | 9,855 | -1,293 | -530.07 | Upgrade
|
| Change in Net Working Capital | 24,245 | 3,965 | -3,691 | 7,252 | 6,771 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.